About this campaign
Looks like your text is -163 character over the limit. Please shorten it to 200 characters or less.
Looks like your text is -163 character over the limit. Please shorten it to 200 characters or less.
A groundbreaking study has revealed a potential new weapon against Clear Cell Sarcoma: the combination of devimistat and hydroxychloroquine may actually stop CCS growth and spread. Building on this incredible promise, our clinical trial (NCT04593758) has successfully and safely completed Phase 1. The hope is real, and it's here. Now, we stand on the brink of Phase 2, a trial that will include adolescents as young as 12. This could be the breakthrough our community has been fighting for.
We face a critical deadline. We have very limited time to secure funding for the Phase 2 drug supply before the pharmaceutical company restructures and shelves the drug.
Without immediate support, this vital trial cannot move forward. Promising research could stall, and hope for a treatment could be delayed for years.
Looks like your text is -9153 character over the limit. Please shorten it to 10000 characters or less.
